Article Text

PDF

Exposure to environmental tobacco smoke and sensitisation in children
  1. E Lannerö1,2,
  2. M Wickman1,3,
  3. M van Hage4,
  4. A Bergström1,
  5. G Pershagen1,5,
  6. L Nordvall6
  1. 1
    Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  2. 2
    Department of Paediatrics, Karolinska University Hospital, Huddinge, Sweden
  3. 3
    Department of Paediatrics, Sach’s Children’s Hospital, Stockholm, Sweden
  4. 4
    Clinical Immunology and Allergy Unit, Department of Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden
  5. 5
    Department of Occupational and Environmental Health, Stockholm County Council, Sweden
  6. 6
    Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
  1. Dr E Lannerö, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden; eva.lannero{at}ki.se

Abstract

Background: Exposure to environmental tobacco smoke (ETS) increases the risk of respiratory illness in children but data are inconclusive regarding the risk of IgE sensitisation.

Objective: To elucidate whether exposure to smoking prenatally and/or postnatally is related to IgE sensitisation in children at 4 years of age.

Methods: As part of a prospective birth cohort study (BAMSE), a total of 4089 families with children answered questionnaires when the child was 2 months, 1, 2 and 4 years old on environmental factors and symptoms of allergic disease. Blood collected at age 4 years from 2614 children was analysed for IgE antibodies to common inhalant and food allergens. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression with adjustments for potential confounders.

Results: There was no evident association between maternal smoking during pregnancy and risk of IgE sensitisation. In contrast, a dose–response effect was found for exposure to ETS from parental smoking during the first few months of life and IgE sensitisation. There was an increased risk of sensitisation to inhalant and/or food allergens (ORadj 1.28 (95% CI 1.01 to 1.62)) among children exposed to ETS at 2 months of age. The risk appeared particularly elevated for indoor inhalant allergens, such as cat (ORadj 1.96 (95% CI 1.28 to 2.99)) and for food allergens (ORadj 1.46 (95% CI 1.11 to 1.93)). The IgE sensitising effect of ETS seemed to be confined to infants of parents without allergic diseases and to ETS exposure during early infancy.

Conclusions: Our data indicate that exposure in early infancy to ETS increases the risk of IgE sensitisation to indoor inhalant and food allergens.

Statistics from Altmetric.com

The association between exposure to tobacco smoke in childhood and risk of atopic sensitisation has been extensively studied but data are inconclusive. In a comprehensive review in 1998, it was concluded that parental smoking is unlikely to increase the risk of IgE sensitisation in children.1 This review, however, primarily dealt with studies of relatively small size and none was a birth cohort study. Subsequent larger birth cohort studies still do not provide a consistent picture. Thus in the German Multicentre Allergy Study, no association was demonstrated between prenatal or postnatal exposure to tobacco smoke and IgE sensitisation to inhalant allergens at the 3 year follow-up whereas an association was seen for sensitisation to food allergens.2 In “The National Asthma Campaign in Manchester”, little or no effect of environmental tobacco smoke (ETS) was found on the development of atopy.3

We have previously reported a strong effect of cigarette smoke exposure in utero on recurrent wheezing in children up to 2 years of age in the BAMSE cohort.4 In the present study, we aimed to assess the separate roles of smoke exposure in utero and postnatally for IgE sensitisation to important inhalant and food allergens at 4 years of age.

MATERIAL AND METHODS

Study subjects

A total of 4089 infants born in Stockholm during 1994–1996 were included in a prospective population based study (BAMSE). The cohort constituted 75% of all eligible children from the area. Details of the study design, inclusion criteria, enrolment and data collection procedure are described in detail elsewhere.57

Exposure assessment

At a median age of 2 months, the parents answered the first questionnaire, which aimed to collect information on exposure to environmental factors before and immediately after birth, such as exposure to tobacco smoke, and parental allergy.6 The socioeconomic status of the parents was assessed using questions about educational level and profession.8 Follow-up questionnaires on symptoms of disease as well as on exposure to ETS and other environmental factors were distributed at 1, 2 and 4 years of age. The response rate of the questionnaire at 4 years of age was 91%. Maternal smoking during pregnancy was defined as smoking one cigarette or more per day during any trimester of pregnancy. Smoking was reported as number of cigarettes smoked for each trimester separately. ETS was defined as maternal and/or paternal smoking of one cigarette or more per day, when the child was 2 months, 1 or 2 years of age. In order to minimise bias from disease related misclassification of exposure, most analyses focused on ETS data in the 2 month questionnaire.

Exposure to locally emitted air pollution from traffic using nitrogen oxides as the indicator was assessed by retrospective methodology.9 10 Emission databases within Stockholm County were available for nitrogen oxides from traffic in 1990 and 2000, and the outdoor levels were calculated using dispersion modelling by interpolation between these years.

IgE antibodies

At 4 years of age, an invitation was sent for a clinical examination which included blood sampling. Samples were successfully obtained from 2614 of 2965 children whose parents agreed to participate in the examination. As a screening procedure, serum IgE antibodies to a mixture of inhalant (Phadiatop) and food (fx5) allergens (ImmunoCAP, Phadia AB, Uppsala, Sweden) were analysed according to the manufacturer’s instructions. Sera that scored positive (⩾0.35 kUA/l) were further analysed for IgE antibodies to the respective individual allergen (birch, timothy, mugwort, cat, dog, horse, Dermatophagoides pteronyssinus, Cladosporium herbarum and cow's milk, hen’s egg, peanut, soy, wheat and cod fish). Only sera positive for at least one single allergen were considered positive. Any inhalant allergen refers to a positive test (⩾0.35 kUA/l) to birch, timothy, mugwort, Dermatophagoides pteronyssinus (dust mite), Cladosporium herbarum (mould), cat, dog and/or horse, and any food allergen to a positive test to any of the foods tested. Separate analyses were also performed using 3.5 kUA/l as the cut-off.

Statistical analyses

The relation between parental smoking and sensitisation was analysed with unconditional logistic regression and the results presented as odds ratios (OR) and 95% confidence intervals (95% CI). Several models were tested, including various covariates. Models were tested which included potential confounders such as sex, parental allergy, socioeconomic status, maternal age, parental education, cat and dog ownership, duration of breastfeeding, older siblings, ambient NOx (nitrogen oxides from traffic) and reported signs of indoor dampness. In our final model, adjustments were made for parental allergic disease, defined as doctor’s diagnosed asthma and asthma medication and/or allergic rhino-conjunctivitis in combination with reported allergy to furred pet and/or pollen in one parent (any heredity) or both (double heredity), and socioeconomic status since only these variables changed the OR estimates for tobacco smoke exposure by more than 3%. Logistic regression was also used for trend analyses, and a p value for the coefficient of <0.05 was considered statistically significant. Statistical analyses were performed with the Stata Statistical Software, release 8.0 (College Station, Texas, USA).

Only children whose parents answered all four questionnaires and had complete information on IgE sensitisation and ETS exposure at baseline (about 2 months of age) were included in the final analyses. This was true for 2534 children, or 62% of the original cohort.

The study was approved by the ethics committee at the Karolinska Institute, Stockholm, Sweden.

RESULTS

Table 1 presents parental smoking when the child was 2 months old in relation to some important exposure characteristics among those who had answered all four questionnaires and provided a blood sample (ie, those eligible for this study) as well as for those representing the whole dataset (ie, those who answered all four questionnaires). There were no significant differences between these two groups. Among the 2534 study participants, 12% of the mothers reported smoking one cigarette or more daily during one or two trimesters of pregnancy and 8% smoked all through pregnancy. At 2 months of age, 20% of children were exposed to ETS from any parent, including 4% exposed to smoking by both parents. Participating children with heredity allergic disease were significantly less exposed to parental smoking than children without such heredity (p = 0.007). Parental smoking was also associated with low maternal age, low socioeconomic status, cat and dog ownership and short duration of breast feeding.

Table 1 Parental smoking* in relation to selected characteristics of children providing blood samples and the whole BAMSE cohort

At 4 years of age, 24% of the children were IgE sensitised, 15% to inhalant allergens, 16% to food allergens and 7% to both. There was no evident increase in the risk of any sensitisation (ie, inhalant and/or food allergens) if the mother had smoked during any of the trimesters (ORadj 1.00 (95% CI 0.61 to 1.66)) but not thereafter (table 2) On the other hand, exposure to ETS at 2 months of age without previous in utero exposure tended to be associated with sensitisation (ORadj 1.26 (95% CI 0.95 to 1.68)) and there was no clear evidence of interaction between in utero and postnatal exposure. For postnatal ETS exposure, with or without exposure in utero, the adjusted ORs for sensitisation to inhalant allergens were 1.12 (95% CI 0.84 to 1.48), for food allergens 1.46 (95% CI 1.11 to 1.93) and for any sensitisation 1.28 (95% CI 1.01 to 1.62).

Table 2 Exposure to maternal smoking during pregnancy or exposure to parental smoking when the infant was about 2 months old and sensitisation (IgE ⩾0.35 kUA/l) at 4 years of age

In table 3, the results on ETS and sensitisation to the most important single allergens are presented. Exposure to ETS was associated with increased risks of sensitisation to cat, horse and mould as well as to food allergens (eg, milk and peanuts). In contrast, no clear association was evident with respect to seasonal outdoor allergens (ie, birch, timothy and mugwort).

Table 3 Parental smoking at 2 months and risk of sensitisation (IgE ⩾0.35 kUA/l) to individual allergens at 4 years of age

Separate analyses of sensitisation using a cut-off value of >3.5 kUA/l of IgE antibody were also performed. Exposure to ETS at 2 months of age resulted in an adjusted OR of 1.26 (95% CI 0.86 to 1.84) for sensitisation to inhalant and/or food allergens. Only sensitisation to cat among single allergens showed a statistically significant increase in risk using the higher cut-off value (ORadj 2.59 (95% CI 1.40 to 4.78)) but the power was low for most other single allergens.

Furthermore, a dose–response effect was found for the association between exposure of ETS at 2 months of age and IgE sensitisation (table 4). Thus when testing for trend (no, one, both parents smoke one cigarette or more daily and both parents smoke >10 cigarettes a day) a significant relationship was found (ptrend = 0.019). A strong trend was shown for sensitisation to food allergens (ptrend = 0.006) but not for inhalant allergens (ptrend = 0.496). Among single allergens, the strongest trend was seen for sensitisation to cat (ptrend = 0.003). A trend was also found for the association between paternal, maternal or biparental smoking and IgE sensitisation (ORadj 1.21 (95% CI 0.91 to 1.61), ORadj 1.24 (95% CI 0.68 to 2.24) and ORadj 1.87 (95% CI 1.06 to 3.31), respectively; ptrend = 0.024). In stratified analyses, the main interaction was seen with parental allergy, where the effect of ETS exposure seemed stronger among children with non-allergic parents (ORadj 1.95 (95% CI 1.19 to 3.20)) than among those with allergic parents (ORadj 1.06 (95% CI 0.47 to 2.35)).

Table 4 Exposure to parental cigarette smoking at 2 months and sensitisation (IgE ⩾0.35 kUA/l) to any inhalant and/or food allergen at 4 years of age

In extended analyses, the role of ETS exposure after 2 months was also assessed (table 5). The strongest association between exposure to ETS and any sensitisation (any inhalant allergen and/or any food allergen) appeared for exposure at 2 months but not thereafter (ORadj 1.63 (95% CI 1.07 to 2.49)). If anything, a decreased risk was suggested among those exposed to ETS at 1 and 2 years only.

Table 5 Exposure to parental cigarette smoking at different ages and sensitisation (IgE ⩾0.35 kUA/l) to any inhalant and/or food allergen at 4 years of age

DISCUSSION

It is evident that exposure to smoke in early life, most particularly exposure of the fetus, causes wheezing in infants.4 1113 However, with regard to atopic sensitisation, the evidence for an effect of smoke exposure has been equivocal.13 The present study provides evidence indicating that exposure in early infancy to tobacco smoke may be associated with an increased risk of atopic sensitisation. The finding of dose–response relationships supports the interpretation of causality. Furthermore, there was also an effect of ETS on IgE antibody responses above 3.5 kUA/l, which suggests that the findings could be of clinical importance. Some reasons for the apparent difference in results compared with previous studies may be the considerably larger size of our study and separation of the effect of exposure to maternal smoking during pregnancy from that of ETS as well as differentiation of sensitisation to indoor perennial and outdoor seasonal allergens. The associations were particularly strong with respect to cat allergen, the most important perennial allergen in our population. It is well known both from clinical experience and studies that exposure to cats leads to more symptoms than exposure to dogs.14 Cat allergen is ubiquitous indoors in our part of the world both in homes and in schools, which contributes to the clinical importance of cat allergy.15 16

It was difficult to fully disentangle the effects of exposure in utero and postnatally in our study because of a high correlation between the two types of exposure. However, no consistent effects on sensitisation were seen among children exposed only prenatally. As regards exposure to ETS, we have relied primarily on the information on exposure collected in the first questionnaire at 2 months of age in order to ensure the prospective nature of data and avoid any bias resulting from modification or misreporting of smoking habits as a consequence of symptoms in the child. Such disease related bias would tend to reverse the association between ETS and sensitisation/allergy, as suggested in our data, where the risk of sensitisation tended to be inversely related to reported parental smoking at 1 and 2 years of age. In Sweden, virtually all mothers attend maternity health clinics and the awareness of the detrimental effects of smoking is very high. Avoidance measures following debut of allergic symptoms in children have been documented in our cohort.17 A contributing explanation as to why the sensitising effect of ETS appears to be confined to exposure during the first few months of life could well be that smoke exposure of infants from their parents is significantly reduced at the end of the first year of life and later, as most children in Sweden start daycare outside their homes at around 1 year of age. Thus by 2 years of age, more than 75% of the children in the BAMSE cohort were in daycare outside their homes. Furthermore, exposure during the first months of life may be particularly detrimental for induction of sensitisation, as indicated for exposure to pollen18 19 and ambient air pollution.20 The lack of focus on a potentially important time window for sensitisation and disease related misclassification of exposure may have contributed to the negative findings in previous studies on ETS exposure and sensitisation. It is also notable that the effect of early exposure to ETS was primarily confined to children without parental allergy, which may partly be attributable to their parent’s significantly higher degree of smoking.

Our data also raise the more general issue of effects on sensitisation by other air pollutants, such as traffic related air pollution. There appears to be a relationship between ambient air pollution and wheezing/asthma in children.2125 With regard to IgE sensitisation, the literature is more ambiguous but several studies20 2427 indicate a relationship between traffic related air pollution and atopy. These findings and our data support the “mucosal concept of atopy”, which implies that sensitisation occurs mainly in the mucosal surfaces of the airways and that mucosal damage and inflammation facilitate sensitisation.28 It is noteworthy that smoke exposure appeared to facilitate sensitisation to the perennial indoor allergens, such as cat, and not to the same extent sensitisation to seasonal pollen allergens (birch, timothy and mugwort) to which we are mainly exposed outdoors where the inhaled dose of tobacco smoke exposure is limited. We also found an increased risk of sensitisation to common foods with exposure to ETS, which supports earlier findings.2 It may seem puzzling that ETS should increase the risk of sensitisation to food allergens. Such allergens are, however, likely to be found in house dust. Swallowed foods are probably also to some extent inhaled or aspirated by a baby, and is why sensitisation appears a conceivable consequence, which could be facilitated by tobacco smoke exposure. Other possibilities are that exposure to the pharynx and pharyngeal lymphoid tissue both of food and inhalant allergen as well as tobacco smoke may be of importance and/or such an influence on the airway and/or pharyngeal epithelium causes a more profound disturbance of the immune system.

Some methodological issues deserve consideration. Since the assessment of exposure to tobacco smoke was done by parental questionnaire based reports, an obvious disadvantage in our design is the lack of objective smoke exposure assessments. However, a strong correlation has been found between assessment of ETS exposure using urinary cotinine and self-reported data.29 30 Data on maternal smoking during pregnancy were collected when the child was about 2 months old. Thus, particularly when it comes to these data, there could be a risk of recall bias, but validation studies indicate that this is not pronounced.3 The potential for selection bias has to be considered. Such bias may be introduced by non-participation due to parental awareness of the hazardous effects of cigarette smoking. Consequently, smokers may to a higher extent than non-smokers have chosen not to participate in the study. A study of non-responders and excluded families of the BAMSE study showed that non-participating parents smoked more than those recruited to the study.5 The study base may thus be less representative of the population, but the risk estimates of health effects related to smoking would most likely not be affected. Another possibility is that parents with allergic diseases would be more willing to join the study compared with parents without such diseases, but no such evidence was found.5 Several potential confounding factors were assessed but only parental allergy and socioeconomic status had any clear effect on the risk estimates. As the study is rich in information on risk factors for allergy and sensitisation in children, which have been extensively assessed and analysed, it is unlikely that uncontrolled confounding is of importance for our findings.

In conclusion, our data indicate that ETS exposure in early infancy increases the risk of sensitisation to indoor inhalant and food allergens. The effects were consistent and strong, and further supported by positive dose–response relationships. These effects may be of great clinical relevance as sensitisation is important for incident asthma among children and adults.

Acknowledgments

Thanks to all colleagues at the Department of Occupational and Environmental Health, Stockholm County Council, Stockholm, Sweden who worked with the BAMSE project. Also thanks to the children and their parents for participating in the BAMSE study.

REFERENCES

View Abstract

Footnotes

  • Funding: This study was funded by the Swedish Heart and Lung Foundation, Stockholm County Council, the Gillbergska Foundation and the Swedish Asthma and Allergy Foundation, The Swedish Foundation for Health Care Sciences and Allergy Research (Vårdalstiftelsen) and The Swedish Research Council.

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.